MAgnetic Resonance Imaging-guided implanTation of Cardioverter DEFibrillators

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1812 participants.

Also called NCT06269692

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 1,812 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06269692
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06269692. Randomized; no masking; primary purpose prevention. Start 2024-04-01 (anticipated); primary completion 2030-04-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
MAgnetic Resonance Imaging-guided implanTation of Cardioverter DEFibrillators
Acronym
SMART-DEF
Condition
Ventricular Tachycardia
Condition
Sudden Cardiac Death
Intervention (Device)
MRI screening
Intervention (Device)
Implantable Loop Recorder
Intervention (Device)
Implantable Cardioverter Defibrillator
Lead sponsor
Central Hospital, Nancy, France (class: other)

Record details

Record id
cardio:ct-nct06269692
Content hash
bb2b6deba8be1a90c6ecdbb4fd9b488b02bcbbf75eeb74e883429df34b2c0061